Here's the live share price of Genomic Valley Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Genomic Valley Biotech has gained 2.54% CAGR. Over the past year, the corresponding return has been -39.49%.
Genomic Valley Biotech’s current P/E of -173.54x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech | -1.51 | 1.39 | -17.36 | -46.58 | -39.49 | 3.81 | 2.54 |
| Tierra Agrotech | -0.63 | -8.65 | -7.86 | 13.39 | -10.83 | -28.22 | -29.13 |
| Nath Bio-Genes (India) | 6.57 | -0.58 | -9.99 | -11.21 | -9.34 | -0.02 | -10.78 |
| Mangalam Seeds | -1.19 | -3.92 | -8.44 | -18.12 | -33.44 | -17.68 | 15.74 |
| Genesis IBRC India | -14.35 | -11.77 | -56.68 | 145.93 | 319.85 | 93.12 | 59.50 |
| Vivo Bio Tech | 4.03 | -11.55 | -15.27 | -21.83 | -35.76 | -0.69 | -12.71 |
| Shree Ganesh Bio-Tech (India) | 6.35 | -2.90 | -8.22 | -15.19 | -40.18 | -20.23 | -35.48 |
| Omega Ag-Seeds (Punjab) | 14.76 | 21.59 | -6.66 | 5.06 | 19.43 | 20.42 | 11.80 |
Over the last one year, Genomic Valley Biotech has declined 39.49% compared to peers like Tierra Agrotech (-10.83%), Nath Bio-Genes (India) (-9.34%), Mangalam Seeds (-33.44%). From a 5 year perspective, Genomic Valley Biotech has outperformed peers relative to Tierra Agrotech (-29.13%) and Nath Bio-Genes (India) (-10.78%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 25.33 | 25.16 |
| 10 | 25.38 | 25.16 |
| 20 | 24.79 | 25.02 |
| 50 | 25.19 | 26.02 |
| 100 | 28.79 | 29.86 |
| 200 | 39.35 | 37.44 |
In the latest quarter, Genomic Valley Biotech saw a drop in promoter holding to 46.06%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 53.94% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Jan 15, 2026, 11:39 PM IST | Genomic Valley Biote - Announcement under Regulation 30 (LODR)-Cessation |
| Jan 15, 2026, 11:34 PM IST | Genomic Valley Biote - Financial Results For The Quarter And Nine Month Ended 31St December 2025 |
| Jan 15, 2026, 11:17 PM IST | Genomic Valley Biote - Board Meeting Outcome for Outcome Of The Board Meeting Dated 15-01-2026 |
| Jan 06, 2026, 11:19 PM IST | Genomic Valley Biote - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 03, 2026, 11:11 PM IST | Genomic Valley Biote - Board Meeting Intimation for Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclos |
Genomic Valley Biotech Ltd. is a Public Limited Listed company incorporated on 15/03/1996 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L01122HR1994PLC033029 and registration number is 033029. Currently Company is involved in the business activities of Growing of cucumbers, gherkins, aubergines, tomatoes, watermelons, cantaloupes , melons and other fruit-bearing vegetables. Company's Total Operating Revenue is Rs. 0.84 Cr. and Equity Capital is Rs. 3.05 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Genomic Valley Biotech is ₹25.51 as on Feb 09, 2026.
The Genomic Valley Biotech is operating in the Agriculture / Horticulture / Lives Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Genomic Valley Biotech is ₹7.79 Cr as on Feb 09, 2026.
Today’s highest and lowest price of Genomic Valley Biotech are ₹25.60 and ₹24.02.
The 52-week high/low is the highest and lowest price at which Genomic Valley Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Genomic Valley Biotech is ₹70.89 and 52-week low of Genomic Valley Biotech is ₹20.10 as on Feb 09, 2026.
The Genomic Valley Biotech has shown returns of 6.2% over the past day, 1.39% for the past month, -17.36% over 3 months, -39.49% over 1 year, 3.81% across 3 years, and 2.54% over 5 years.
P/E ratio of and PB ratio of Genomic Valley Biotech are -173.54 and 1.98 on Feb 09, 2026. While the company gives a dividend yield of 0.00 per annum.